Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.
Tagged prior art · clear
In Meiresonne v. Google, Inc. , [2016-1755] (March 7, 2017), the Federal Circuit affirmed the PTAB determination that claims 16, 17, 19 and 20 of U.S. Patent No. 8,156,096 on a system whereby a user can identify a supplier of goods or services over the…
Inter Partes Review (IPR) proceedings are limited to prior art challenges for printed prior art. Although prior art typically includes drawings that illustrate physical structures, the description of those drawings may only discuss what is illustrated and…
The second prong of the Alice test is commonly abbreviated as requiring an “inventive concept.” Of course, that same nomenclature is used by many international patent laws as a synonym for nonobviousness. Can a defendant then cite prior art to…
The recent decision on Teva Pharmaceutical Industries Ltd. v. Astrazeneca Pharmaceuticals LP raises the issue of ‘secret prior art’ and also raises speculation on how (if at all) the America Invents Act will change the patent landscape in this…
Microsoft Corporation, one of the largest software companies of the world, has posed an even larger question before the U.S. Supreme Court pertaining to Patent law. Patent law has been brought to an edge now, pending decision of the Supreme Court in the…
